compostos antivirais

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Saved in:
Bibliographic Details
Main Authors ROLF WAGNER, JOHN T. RANDOLPH, WARREN M. KATI, CHARLES A. FLENTGE, MARY E. BELLIZZI, DOUGLAS K. HUTCHINSON, SEBLE H. WAGAW, JEAN C. CALIFANO, MARK A. MATULENKO, WENKE LI, TODD N. SOLTWEDEL, ALLAN C. KRUEGER, YI GAO, KEVIN R. WOLLER, PAMELA L. DONNER, RYAN G. KEDDY, DAVID DEGOEY, SACHIN V. PATEL, DANIEL D. CASPI, KATHY SARRIS, TAMMIE K. JINKERSON, CHARLES W. HUTCHINS, JOHN K. PRATT, CLARENCE J. MARING, DAVID A. BETEBENNER, LISSA T. NELSON, MICHAEL D. TUFANO, DACHUN LIU, CHRISTOPHER E. MOTTER
Format Patent
LanguagePortuguese
Published 15.05.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Bibliography:Application Number: BR2010PI04894